Basic
10
แน5442027
78%
chance
1D
1W
1M
ALL
Resolves YES if the FDA grants full approval for the commercial sale of any mRNA vaccine against any strain of influenza in the United States before January 1, 2028. This does not include emergency use authorization or other forms of limited authorization. Resolves NO otherwise.
Get แน600 play money
Related questions
Related questions
Will FDA approve any mRNA vaccine against any type of herpes simplex infection before 2028?
63% chance
Will FDA approve any mRNA vaccine against malaria before 2028?
45% chance
Will FDA approve any mRNA vaccine against any type of human papillomavirus infection before 2028?
36% chance
Will FDA approve any mRNA vaccine against non-small-cell lung carcinoma before 2028?
43% chance
Will FDA approve any mRNA vaccine against squamous cell carcinoma before 2028?
35% chance
Will FDA approve any mRNA vaccine against melanoma before 2028?
49% chance
Will FDA approve any mRNA vaccine against any type of breast cancer before 2028?
31% chance
Will FDA approve any mRNA vaccine against myeloid leukemia before 2028?
34% chance
Will FDA approve more than 10 new mRNA based vaccines before 2028?
75% chance
Will an H5N1 mRNA vaccine be developed and enter "late stage" human trials (or wider release) by July 2025?
60% chance